| Income Statement |
| Operating Expenses | 1.10M |
|
| Research and Development Expense | 524.78K |
| Selling, General and Administrative Expense | 578.70K |
| Operating Income | -1.10M |
| Net Income | -1.15M |
| Net Income Common Stock | -1.15M |
| Net Income Common Stock (USD) | -1.15M |
| Consolidated Income | -1.15M |
| Earnings per Basic Share | -0.03 |
| Earnings per Basic Share (USD) | -0.03 |
| Earnings per Diluted Share | -0.03 |
| Earning Before Interest & Taxes (EBIT) | -1.15M |
| Earning Before Interest & Taxes (USD) | -1.15M |
| Weighted Average Shares | 41.94M |
| Weighted Average Shares Diluted | 41.94M |
| Balance Sheet |
| Cash and Equivalents | 4.82M |
| Cash and Equivalents (USD) | 4.82M |
| Investments | 4.59M |
| Investments Current | 4.59M |
| Trade and Non-Trade Receivables | 35.44K |
| Current Assets | 9.43M |
| Total Assets | 9.46M |
| Current Liabilities | 114.76K |
| Total Liabilities | 114.76K |
| Accumulated Retained Earnings (Deficit) | -40.73M |
| Shareholders Equity | 9.35M |
| Shareholders Equity (USD) | 9.35M |
| Assets Non-Current | 35.44K |
| Trade and Non-Trade Payables | 34.01K |
| Cash Flow |
| Net Cash Flow from Financing | -330.61K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.53M |
| Issuance (Repayment) of Debt Securities | -330.61K |
| Net Cash Flow from Operations | -1.20M |
| Share Based Compensation | 107.59K |